NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like 4 Biotechs to Make a Move On Now January 23, 2017 Top 5 Biosimilars Drug Stocks to Buy Right Now November 12, 2017 5 Biotechs the Super-Rich Are Favoring in 2017 (So Far) March 21, 2017
